Related Experiment Video
Updated: Jun 21, 2026
13:36
Detection of MicroRNAs in Microglia by Real-time PCR in Normal CNS and During Neuroinflammation
Published on: July 23, 2012
19.5K
A Comprehensive microRNA-seq Transcriptomic Analysis of Tay-Sachs Disease Mice Revealed Distinct miRNA Profiles in
Beyza Kaya1, Mehmet Emin Orhan2, Selman Yanbul1
1Department of Molecular Biology and Genetics, İzmir Institute of Technology, İzmir, Turkey.
Journal of Molecular Neuroscience : MN
|August 9, 2025
Summary
This study identifies specific microRNAs (miRNAs) altered in a new mouse model of Tay-Sachs disease (TSD). These findings offer potential targets for novel miRNA-based therapies to treat this rare neurodegenerative disorder.
Area of Science:
- Neuroscience
- Genetics
- Molecular Biology
Background:
- Tay-Sachs disease (TSD) is a rare, fatal lysosomal storage disorder caused by mutations in the HEXA gene, leading to GM2 ganglioside accumulation in the central nervous system (CNS).
- Neurodegeneration and neuroinflammation are key pathological features of TSD, observed in a novel Hexa-/-Neu3-/- mouse model.
- MicroRNAs (miRNAs) play crucial roles in gene regulation and are implicated in various neurological disorders, but their specific roles in TSD pathogenesis require further elucidation.
Purpose of the Study:
- To comprehensively profile microRNA (miRNA) expression in neuroglial cells of a novel early-onset Tay-Sachs disease (TSD) mouse model (Hexa-/-Neu3-/-).
- To identify novel disease-specific miRNAs and their potential targets involved in the neuropathology of GM2 gangliosidosis.
- To explore the potential of miRNA-based therapeutic strategies for TSD.
Main Methods:
- Utilized next-generation sequencing for complete miRNA profiling in neuroglial cells from Hexa-/-Neu3-/- mice and age-matched wild-type (WT) controls.
- Analyzed KEGG and Reactome pathways related to neurodegeneration, neuroinflammation, and sphingolipid metabolism.
- Compared miRNA expression profiles between TSD model mice and WT mice.
Main Results:
- Identified significant differential expression of several miRNAs in Hexa-/-Neu3-/- neuroglial cells compared to WT.
- Found upregulated miRNAs including miR-708-5p, miR-672-5p, miR-204-5p, miR-335-5p, and miR-296-3p.
- Observed downregulated miRNAs including miR-10 b-5p, miR-615-3p, miR-196a-5p, miR-214-5p, and miR-199a-5p, potentially linked to TSD pathophysiology.
Conclusions:
- The study provides the first comprehensive miRNA profile in this innovative TSD mouse model.
- The identified differentially expressed miRNAs offer insights into the neuropathological mechanisms of GM2 gangliosidosis.
- These findings support the development of targeted miRNA-based therapeutic strategies for Tay-Sachs disease patients.
